metformin steady state study [Regulatives / Guidelines]

posted by jagankm  – 2011-06-02 12:35 (5132 d 21:55 ago) – Posting: # 7056
Views: 10,437

❝ As per FDA's Bioequivalence recommendations…


Dear Dr,

Thank you for your response.

we are planning this study for EU submission.

on scientific basis when there is no accumulation of drug on repeated administration what is the use of conducting steady state study. SPC of innovator itself noticing there is no accumulation of metformin after repeated administration. in this regard is it necessary to for steady state study as per guidelines. is there any way to skip to conduct steady state study for metformin for EU submission.

please suggest…


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Jaime]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
73 visitors (0 registered, 73 guests [including 40 identified bots]).
Forum time: 10:30 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5